Tamaki, Nobuharu

Publishing since 1970 (Dinosaur)

Has published 112 publications in 41 years

Number of publications published per year by Tamaki, Nobuharu. (Source : PubMed)

Distribution of publications types for Tamaki, Nobuharu. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ekuni D, Tomofuji T, Irie K, Kasuyama K, Umakoshi M, Azuma T, Tamaki N, Sanbe T, Endo Y, Yamamoto T, Nishida T, Morita M. Effects of periodontitis on aortic insulin resistance in an obese rat model.  Lab. Invest.  2010;90;3  
•  Tamaki K, Sasano H, Maruo Y, Takahashi Y, Miyashita M, Moriya T, Sato Y, Hirakawa H, Tamaki N, Watanabe M, Ishida T, Ohuchi N. Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.  Cancer Sci.  2010  
•  Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Ikeda H, Itakura J, Takahashi Y, Asahina Y, Higaki M, Enomoto N, Izumi N. A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis.  Hepatol. Res.  2010  
•  Narita M, Hatano E, Tamaki N, Yamanaka K, Yanagida A, Nagata H, Asechi H, Takada Y, Ikai I, Uemoto S. Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver.  J. Gastroenterol. Hepatol.  2009;24;6  
•  Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, Ikai I, Matsuzaki K, Uemoto S. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.  Hepatology  2009;49;6  
•  Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, Uemoto S. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.  Int. J. Oncol.  2009;34;5  
•  Kuwatani M, Kawakami H, Eto K, Haba S, Shiga T, Tamaki N, Asaka M. Modalities for evaluating chemotherapeutic efficacy and survival time in patients with advanced pancreatic cancer: comparison between FDG-PET, CT, and serum tumor markers.  Intern. Med.  2009;48;11  
•  Hasebe N, Moroi M, Nishimura M, Hara K, Hase H, Hashimoto A, Kumita S, Haze K, Momose M, Nagai Y, Sugimoto T, Kusano E, Akiba T, Nakata T, Nishimura T, Tamaki N, Kikuchi K. Prognostic study of cardiac events in Japanese high risk hemodialysis patients using I-BMIPP-SPECT: B-SAFE study design.  Ther Apher Dial  2008;12;6  
•  Iwaisako K, Hatano E, Taura K, Nakajima A, Tada M, Seo S, Tamaki N, Sato F, Ikai I, Uemoto S, Kinoshita M. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.  J. Hepatol.  2008;49;5  
•  Nishimura R, Tominaga T, Kimura M, Yanagita Y, Tamaki N, Asaishi K, Okamoto Y, Okuyama N, Takeuchi H, Inaba M, Doi T. Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.  Anticancer Drugs  2008;19;9  

[ See timeline ] [ See all publications ]